Cargando…

TWEAK/Fn14 system and crescent formation in IgA nephropathy

BACKGROUND: The TNF-like weak inducer of apoptosis (TWEAK) contributes to kidney inflammation producing secretion by renal cells. The present study examined whether the level of TWEAK is associated with histologic findings in patients with IgA nephropathy (IgAN). METHODS: The levels of urinary TWEAK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasaki, Yohei, Shimizu, Yoshio, Suzuki, Yusuke, Horikoshi, Satoshi, Tomino, Yasuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363378/ https://www.ncbi.nlm.nih.gov/pubmed/25885587 http://dx.doi.org/10.1186/s12882-015-0022-8

Ejemplares similares

Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy
por: Satake, Kenji, et al.
Publicado: (2014)

Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy
por: Aizawa, Masashi, et al.
Publicado: (2014)

Nationwide survey on current treatments for IgA nephropathy in Japan
por: Matsuzaki, Keiichi, et al.
Publicado: (2013)

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
por: Nakata, Junichiro, et al.
Publicado: (2014)

Different Pathological Roles of Toll-Like Receptor 9 on Mucosal B Cells and Dendritic Cells in Murine IgA Nephropathy
por: Kajiyama, Tadahiro, et al.
Publicado: (2011)

TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013)

The Kinetics of Glomerular Deposition of Nephritogenic IgA
por: Yamaji, Kenji, et al.
Publicado: (2014)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
por: Yasutake, Junichi, et al.
Publicado: (2015)

Diagnosis and treatment of patients with IgA nephropathy in Japan
por: Tomino, Yasuhiko
Publicado: (2016)

Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2014)

Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy
por: Maruyama, Shuntaro, et al.
Publicado: (2016)

Pathological Role of Tonsillar B Cells in IgA Nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2011)

Significance of Urinary Full-Length Megalin in Patients with IgA Nephropathy
por: Seki, Takuto, et al.
Publicado: (2014)

Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)

Crescents and IgA Nephropathy: A Delicate Marriage
por: Trimarchi, Hernán, et al.
Publicado: (2022)

TWEAK/Fn14 Activation Participates in Skin Inflammation
por: Liu, Qilu, et al.
Publicado: (2017)

A Case of Arteriovenous Fistula after Renal Biopsy in an IgA Nephropathy Patient with Macroscopic Hematuria
por: Horikoshi, Satoshi, et al.
Publicado: (2013)

Dietary Zinc Is a Key Environmental Modifier in the Progression of IgA Nephropathy
por: Maiguma, Masayuki, et al.
Publicado: (2014)

A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway
por: Bhattacharjee, Mitali, et al.
Publicado: (2012)

Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?
por: Ring, Troels, et al.
Publicado: (2015)

Clinical outcomes of IgA nephropathy patients with different proportions of crescents
por: Zhang, Wang, et al.
Publicado: (2017)

Retrospective analysis of crescent score in clinical prognosis of IgA nephropathy
por: Chen, Ying, et al.
Publicado: (2022)

Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation
por: Di, Dingxin, et al.
Publicado: (2023)

Nomogram for the prediction of crescent formation in IgA nephropathy patients: a retrospective study
por: Lin, Zaoqiang, et al.
Publicado: (2023)

Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy
por: Kim, Yang Gyun, et al.
Publicado: (2015)

Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway
por: Stock, Ariel D., et al.
Publicado: (2013)

The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson’s disease
por: Mustafa, S., et al.
Publicado: (2016)

The TWEAK/Fn14/CD163 axis—implications for metabolic disease
por: Ratajczak, Wiktoria, et al.
Publicado: (2021)

TWEAK/Fn14 Signalling Regulates the Tissue Microenvironment in Chronic Pancreatitis
por: Abu Bakar, N. Dianah B., et al.
Publicado: (2023)

Pathological Scenario with the Mannose-Binding Lectin in Patients with IgA Nephropathy
por: Ohsawa, Isao, et al.
Publicado: (2012)

A validation study of crescents in predicting ESRD in patients with IgA nephropathy
por: Zhang, Xiaoyan, et al.
Publicado: (2018)

A novel clinical−radiomic nomogram for the crescent status in IgA nephropathy
por: Qin, Xiachuan, et al.
Publicado: (2023)

Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy
por: Sonoda, Yuji, et al.
Publicado: (2015)

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
por: Yamada, Koshi, et al.
Publicado: (2017)

Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function
por: Onda, Kisara, et al.
Publicado: (2011)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases
por: Blanco-Colio, Luis M.
Publicado: (2014)

Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice
por: Meijboom, Katharina E., et al.
Publicado: (2022)

The TWEAK Receptor Fn14 is a Novel Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment
por: Zhou, Hong, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uld2kl89eqq9kp7cl46rnfn24n